NATCO Pharma Limited (BOM: 524816)
India
· Delayed Price · Currency is INR
1,418.75
0.00 (0.00%)
At close: Dec 20, 2024
NATCO Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 253,790 | 170,522 | 102,795 | 138,013 | 150,529 | 92,044 | Upgrade
|
Market Cap Growth | 62.65% | 65.89% | -25.52% | -8.31% | 63.54% | -12.17% | Upgrade
|
Enterprise Value | 231,309 | 160,841 | 93,605 | 133,992 | 144,005 | 84,751 | Upgrade
|
Last Close Price | 1418.75 | 948.61 | 555.81 | 740.10 | 802.16 | 488.33 | Upgrade
|
PE Ratio | 13.05 | 12.28 | 14.37 | 81.18 | 34.14 | 19.97 | Upgrade
|
PS Ratio | 5.57 | 4.26 | 3.80 | 7.09 | 7.32 | 4.81 | Upgrade
|
PB Ratio | 3.55 | 2.91 | 2.11 | 3.24 | 3.65 | 2.43 | Upgrade
|
P/TBV Ratio | 3.68 | 3.01 | 2.19 | 3.34 | 3.66 | 2.44 | Upgrade
|
P/FCF Ratio | 18.75 | 19.55 | 14.63 | - | 340.56 | 149.42 | Upgrade
|
P/OCF Ratio | 14.82 | 14.07 | 12.11 | 296.80 | 50.38 | 22.06 | Upgrade
|
EV/Sales Ratio | 5.07 | 4.02 | 3.46 | 6.88 | 7.00 | 4.43 | Upgrade
|
EV/EBITDA Ratio | 9.74 | 9.19 | 9.68 | 51.54 | 23.74 | 14.56 | Upgrade
|
EV/EBIT Ratio | 10.56 | 10.24 | 11.56 | 108.58 | 29.19 | 17.45 | Upgrade
|
EV/FCF Ratio | 17.06 | 18.44 | 13.32 | - | 325.80 | 137.58 | Upgrade
|
Debt / Equity Ratio | 0.03 | 0.07 | 0.04 | 0.10 | 0.07 | 0.09 | Upgrade
|
Debt / EBITDA Ratio | 0.09 | 0.22 | 0.18 | 1.64 | 0.47 | 0.57 | Upgrade
|
Debt / FCF Ratio | 0.15 | 0.44 | 0.25 | - | 6.42 | 5.35 | Upgrade
|
Asset Turnover | 0.63 | 0.64 | 0.50 | 0.39 | 0.44 | 0.43 | Upgrade
|
Inventory Turnover | 0.94 | 0.94 | 0.78 | 0.66 | 0.66 | 0.63 | Upgrade
|
Quick Ratio | 3.87 | 2.72 | 2.47 | 2.02 | 2.48 | 2.23 | Upgrade
|
Current Ratio | 4.96 | 4.14 | 4.39 | 3.50 | 4.46 | 3.39 | Upgrade
|
Return on Equity (ROE) | 31.23% | 25.88% | 15.66% | 4.05% | 11.19% | 12.59% | Upgrade
|
Return on Assets (ROA) | 18.89% | 15.63% | 9.40% | 1.56% | 6.57% | 6.83% | Upgrade
|
Return on Capital (ROIC) | 21.22% | 17.39% | 10.39% | 1.69% | 7.24% | 7.60% | Upgrade
|
Earnings Yield | 7.65% | 8.14% | 6.96% | 1.23% | 2.93% | 5.01% | Upgrade
|
FCF Yield | 5.33% | 5.11% | 6.84% | -1.35% | 0.29% | 0.67% | Upgrade
|
Dividend Yield | 0.41% | 1.00% | 0.99% | 0.61% | 0.65% | 1.38% | Upgrade
|
Payout Ratio | 5.10% | 12.30% | 14.04% | 48.35% | 25.83% | 27.65% | Upgrade
|
Buyback Yield / Dilution | 1.16% | 1.67% | -0.08% | 0.05% | -0.02% | 1.26% | Upgrade
|
Total Shareholder Return | 1.16% | 2.68% | 0.91% | 0.65% | 0.63% | 2.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.